Intact Breast Lesion Excision System (BLES) ישראל - עברית - Ministry of Health

intact breast lesion excision system (bles)

a.m.i. technologies, ltd. - רופא - electrosurgical biopsy device

contact lenses ישראל - עברית - Ministry of Health

contact lenses

retina optica - כלל האוכלוסיה - עדשות מגע

contact lenses ישראל - עברית - Ministry of Health

contact lenses

kontakt linsen (israe - כלל האוכלוסיה - עדשות מגע

אינפנריקס אי.פי.וי. איץ'.אי.בי ישראל - עברית - Ministry of Health

אינפנריקס אי.פי.וי. איץ'.אי.בי

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens

Viscoelastic Drops and Gels - Washing & Lubricating the Eyes and Contact Lenses ישראל - עברית - Ministry of Health

viscoelastic drops and gels - washing & lubricating the eyes and contact lenses

trimaco medical division ltd. - כלל האוכלוסיה - ophthalmic drops and gels for contact lenses (rigid and soft) - for use on the eye and out of the eye

בוסטריקס פוליו ישראל - עברית - Ministry of Health

בוסטריקס פוליו

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.